Test Price
1,100 AEDโ Home Collection Available
H7N7 and Influenza A RNA Detection Qualitative Test in UAE | 1100 AED | Dubai Healthcare City
Executive Summary & Core Metrics
DNA Labs UAE offers the H7N7 and Influenza A RNA Detection Qualitative Test at 1100 AED with preliminary results available within 36 hours and a final report by the 4th working day. This molecular assay delivers diagnostic sensitivity exceeding 99.9% through real-time PCR with confirmatory whole genome sequencing, compliant with DHA diagnostic standards.
- โAccuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- โPremium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- โClinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- โInsurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This qualitative real-time PCR test detects RNA from H7N7 avian influenza virus and other Influenza A subtypes with confirmatory whole genome sequencing (WGS). The respiratory swab specimen is processed under strict ISO 9001:2015 accredited protocols to ensure reliable subtyping and differentiation from seasonal influenza strains.
| Feature | Our Test (H7N7 & Inf A RNA PCR) | Closest Alternative (Rapid Antigen) |
|---|---|---|
| Method | Real-Time PCR (qPCR) + Whole Genome Sequencing | Lateral Flow Immunochromatography |
| Diagnostic Sensitivity | >99.9% | 50โ70% |
| Turnaround Time | Phone: 36 hrs / Report: 4th Working Day | 15โ30 minutes |
| H7N7 Specificity | Confirmed (subtyping via WGS) | Cannot distinguish H7N7 |
| Regulatory Status | DHA / MOHAP Approved, ISO 9001:2015 | Limited POCT validation |
Physician Insight & Safety Protocols
Dr. Ajay Singh DHA: 36234132
โThis molecular assay is a definitive tool for identifying avian influenza subtypes. However, a negative result does not entirely exclude infection, especially if sampling was suboptimal. Please discuss your exposure history and symptoms with our clinical team for integrated interpretation and appropriate follow-up care.โ
Advisory Safety Notice
โ ๏ธ Pre-Test Considerations
Do not discontinue prescribed medication without consulting your doctor.
Antiviral therapy may lower viral RNA levels below detection threshold; disclose any recent medication use during pre-test consultation to ensure result accuracy.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria:
- Recent antiviral administration (within 48 hours) may lower viral load below detection threshold.
- Inability to safely provide a respiratory sample (e.g., uncontrolled severe cough).
- Active nosebleed or recent nasal surgery contraindicating swab collection.
Seek Emergency Care If You Experience:
- Severe difficulty breathing or bluish lips/face
- Persistent chest pain or pressure
- New confusion or inability to stay awake
Patient FAQ & Clinical Guidance
1. What is the accuracy of the H7N7 and Influenza A RNA test?
The test achieves >99.9% sensitivity and specificity using real-time PCR with whole genome sequencing confirmation, ensuring reliable subtype identification and ruling out cross-reactivity with seasonal influenza strains.
2. How should I prepare for the respiratory swab collection?
Fasting is not required; simply avoid eating, drinking, or smoking 30 minutes before swab collection to ensure sample integrity. Our mobile phlebotomist will collect the nasopharyngeal specimen at your home between 8 AM and 11 PM.
3. When will I receive my results?
Preliminary results are available by phone within 36 hours, with the final report emailed by the 4th working day, compliant with DHA turnaround time standards.
4. What does a positive result mean for my treatment plan?
A positive H7N7 or Influenza A result indicates active viral shedding. Our clinical team provides telephonic guidance on treatment options, isolation protocols, and reporting obligations under UAE communicable disease surveillance regulations.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance and Data Protection
DNA Labs UAE operates under DHA Facility License Number 1143 and maintains full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the collection, processing, and storage of patient health information. All genetic and diagnostic data is encrypted and accessed only by authorized medical personnel.
Laboratory operations adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure electronic health record management and telemedicine protocols. Patient consent and clinical safety standards follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Cert: INT/EGQ/2509DA/3139DHA License: 1143
Clinical & Logistical Metadata
| Test Name | H7N7 and Influenza A RNA Detection Qualitative Test |
| Price (AED) | 1100 AED |
| Turnaround Time | Preliminary: 36 hours (phone) / Final Report: 4th Working Day |
| Sample Type / Matrix | Respiratory Swab (Nasopharyngeal/Oropharyngeal) |
| Methodology Used | Real-Time PCR (qPCR) with Whole Genome Sequencing Confirmation |
| ICD-10-CM Code | J09.X2, J10.1, Z20.828 |
| LOINC Code | 34487-9 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians